Related Experiment Video
Updated: Aug 4, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic Reoviruses: Can These Emerging Zoonotic Reoviruses Be Tamed and Utilized?
Zhen Yun Siew1, Alson Loh2, Sharrada Segeran3
1School of Pharmacy, University of Nottingham Malaysia, Semenyih, Malaysia.
Abstract:
Orthoreovirus is a nonenveloped double-stranded RNA virus under the Reoviridae family. This group of viruses, especially mammalian orthoreovirus (MRV), are reported with great therapeutic values due to their oncolytic effects. In this review, the life cycle and oncolytic effect of MRV and a few emerging reoviruses were summarized. This article also highlights the challenges and strategies of utilizing MRV and the emerging reoviruses, avian orthoreovirus (ARV) and pteropine orthoreovirus (PRV), as oncolytic viruses (OVs). Besides, the emergence of potential ARV and PRV as OVs were discussed in comparison to MRV. Finally, the risk of reovirus as zoonosis or reverse zoonosis (zooanthroponosis) were debated, and concerns were raised in this article, which warrant continue surveillance of reovirus (MRV, ARV, and PRV) in animals, humans, and the environment.
Insights
Mammalian orthoreovirus (MRV) and other reoviruses show promise as oncolytic viruses (OVs) targeting cancer. Further research is needed to address challenges and assess zoonotic risks for safe application.
Area of Science:
- Virology
- Oncology
- Biotechnology
Background:
- Orthoreoviruses, belonging to the Reoviridae family, are nonenveloped, double-stranded RNA viruses.
- Mammalian orthoreovirus (MRV) exhibits significant oncolytic effects, making it a candidate for cancer therapy.
Approach:
- This review summarizes the life cycle and oncolytic properties of MRV.
- It also examines emerging reoviruses, avian orthoreovirus (ARV) and pteropine orthoreovirus (PRV), as potential oncolytic viruses (OVs).
Key Points:
- Challenges and strategies for utilizing MRV, ARV, and PRV as OVs are discussed.
- The potential of ARV and PRV as OVs is compared to MRV.
- The review addresses the zoonotic and reverse zoonotic potential of reoviruses.
Conclusions:
- Continued surveillance of MRV, ARV, and PRV in animals, humans, and the environment is crucial.
- Understanding reovirus biology is key to their development as effective and safe oncolytic agents.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Viral Recombination

